Literature DB >> 2858035

Nalidixic-acid-resistant Shigella dysenteriae I.

B R Panhotra, B Desai, P L Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2858035     DOI： 10.1016/s0140-6736(85)91310-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 2.  Transferable Mechanisms of Quinolone Resistance from 1998 Onward.

Authors:  Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

Review 3.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.

Authors:  F Rogerie; D Ott; J Vandepitte; L Verbist; P Lemmens; I Habiyaremye
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

5.  The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Authors:  R Vanhoof; J M Hubrechts; E Roebben; H J Nyssen; E Nulens; J Leger; N De Schepper
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

6.  High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update.

Authors:  N Harnett
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

7.  Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease.

Authors:  B R Panhotra; A K Saxena; Ali M Al-Arabi Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

8.  Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease.

Authors:  B R Panhotra; A K Saxena; Ali M Al-Arabi Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2004 Jul-Aug       Impact factor: 1.526
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.